Related Experiment Videos
Lentiviral vectors targeted to MHC II are effective in immunization
Alexander Ageichik1, Christian J Buchholz, Mary K Collins
1MRC Medical Molecular Virology Centre, Division of Infection and Immunity, University College London, United Kingdom.
Human Gene Therapy
|January 21, 2011
Abstract:
Abstract vectors (LVs) that are targeted to APC using a chimeric measles virus (MV) hemagglutinin (H). The MV H protein is mutated to prevent binding to MV receptors and incorporates a single-chain antibody that recognizes murine major histocompatibility complex class II (MHC II). This targeted LV is highly efficient in transduction of freshly isolated mouse B cells and dendritic cells. MHC II-positive cells in spleen are transduced after intravenous injection, and a robust immune response to an antigen transgene is generated.